Transcode Therapeutics, Inc. SEC filings RNAZ
Transcode Therapeutics, Inc. has 324 filings in SEC EDGAR's recent list, going back to Dec 18, 2020. Its latest annual report, Form ARS, was filed on Jun 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Jul 20, 2026 | — |
| 424B3 | Prospectus | Jul 20, 2026 | — |
| S-1 | Registration statement | May 1, 2026 | — |
| S-3 | Shelf registration | Apr 30, 2026 | — |
| S-3 | Shelf registration | Dec 12, 2025 | — |
| 424B5 | Prospectus supplement | Mar 25, 2025 | — |
| S-1 | Registration statement | Dec 6, 2024 | — |
| 424B5 | Prospectus supplement | Jul 24, 2024 | — |
| 424B5 | Prospectus supplement | Jul 22, 2024 | — |
| 424B4 | Prospectus | Jan 22, 2024 | — |
| S-1/A | Amended registration statement | Jan 18, 2024 | — |
| S-1/A | Amended registration statement | Jan 17, 2024 | — |
| S-1 | Registration statement | Jan 11, 2024 | — |
| 424B5 | Prospectus supplement | Dec 1, 2023 | — |
| 424B5 | Prospectus supplement | Oct 26, 2023 | — |
| 424B4 | Prospectus | Sep 27, 2023 | — |
| S-1/A | Amended registration statement | Sep 25, 2023 | — |
| S-1/A | Amended registration statement | Sep 11, 2023 | — |
| S-1 | Registration statement | Aug 29, 2023 | — |
| 424B4 | Prospectus | Jun 7, 2023 | — |
| S-1/A | Amended registration statement | Jun 6, 2023 | — |
| S-1/A | Amended registration statement | Jun 5, 2023 | — |
| S-1 | Registration statement | May 19, 2023 | — |
| 424B5 | Prospectus supplement | Apr 14, 2023 | — |
| 424B5 | Prospectus supplement | Feb 17, 2023 | — |
| S-1 | Registration statement | Feb 1, 2023 | — |
| S-3 | Shelf registration | Dec 13, 2022 | — |
| S-1/A | Amended registration statement | Nov 30, 2022 | — |
| S-1 | Registration statement | Nov 28, 2022 | — |
| S-8 | Employee stock plan registration | Jun 9, 2022 | — |
| S-8 | Employee stock plan registration | Jul 13, 2021 | — |
| 424B4 | Prospectus | Jul 9, 2021 | — |
| S-1/A | Amended registration statement | Jun 2, 2021 | — |
| S-1/A | Amended registration statement | May 3, 2021 | — |
| S-1/A | Amended registration statement | Apr 16, 2021 | — |
| S-1/A | Amended registration statement | Apr 8, 2021 | — |
| S-1/A | Amended registration statement | Mar 24, 2021 | — |
| S-1 | Registration statement | Feb 26, 2021 | — |
Showing 38 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- RNAZ (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1829635
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.